The intense demand for GLP-1 agonists stems from their proven efficacy in managing type 2 diabetes and, increasingly, in facilitating significant weight loss. However, patients often face substantial ...

Clinic Secret is a telehealth provider specializing in prescription therapies for weight loss. It connects patients with U.S.-licensed doctors who review medical information and prescribe medications, ...

New Evidation CEO Leslie Olay Wilberforce speaks at a Reuters event earlier this year. Earlier this year, San Francisco-based ...

The U.S. Food & Drug Administration (FDA) has approved certain GLP-1 drugs for commercialization and use, including liraglutide ...

For patients with type 2 diabetes, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are associated with an increased risk for gastroesophageal reflux disease (GERD) and its complications compared ...

More than one-third of people who helped develop the 2023 guidelines for treating children with obesity had undisclosed ...

Landmark trials have shown that GLP-1 receptor agonists, originally developed for diabetes and weight loss, also provide ...

GLP-1 drugs, which have seen widespread success, have been linked to a number of cases of pancreatitis in the UK, which have led to hospitalisations and even deaths.

Overpaying for GLP-1 medications is extremely common, with a new data analysis of 102,166 drugs showing that 92% of those prescriptions could have been filled at a lower price. The DoseSpot analysis ...

GLP-1 drugs bought online or at compound pharmacies could cause harm, according to Tennessee Attorney General Jonathan Skrmetti.

More than 90% of GLP-1 prescriptions could be filled at lower cost, analysis finds A $10.2 million savings across more than 100,000 prescriptions over three months, extrapolated across the nearly ...

MindRank has shared the skinny on its oral GLP-1 receptor agonist, publishing data from a Chinese phase 2b obesity trial that suggests efficacy is in the same ballpark as Eli Lilly’s orforglipron.